Faruqi & Faruqi Investigating Tvardi Therapeutics for Securities Violations.

miércoles, 3 de diciembre de 2025, 9:58 am ET1 min de lectura
TVRD--

Faruqi & Faruqi, a national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. after its shares plummeted over 80% on October 13, 2025. Investors who suffered significant losses in Tvardi stock or options can contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their options.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios